Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 22, Number 6—June 2016

MERS-CoV Antibodies in Humans, Africa, 2013–2014

Anne M. Liljander1, Benjamin Meyer1, Joerg Jores, Marcel A. Müller, Erik Lattwein, Ian Njeru, Bernard Bett, Christian DrostenComments to Author , and Victor Max Corman
Author affiliations: International Livestock Research Institute, Nairobi, Kenya (A. Liljander, J. Jores, B. Bett); University of Bonn Medical Centre, Bonn, Germany (B. Meyer, M.A. Müller, C. Drosten, V.M. Corman); University of Bern, Vetsuisse Faculty, Bern, Switzerland (J. Jores); EUROIMMUN AG, Lübeck, Germany (E. Lattwein); Ministry of Health, Nairobi, Kenya (I. Njeru); German Centre for Infection Research, Bonn (C. Drosten, V.M. Corman)

Main Article


Seropositivity for Middle East respiratory syndrome coronavirus in samples from humans in Kenya, 2013–2014*

County No. samples tested No. (%) positive by rELISA No. (%) positive by rELISA and with >50% plaque reduction at 1:20 dilution
Garissa 559 4 (0.72) 0
Tana River 563 12 (2.13) 2 (0.36)
Total 1,122 16 (1.43) 2 (0.18)

*rELISA, recombinant ELISA.

Main Article

1These authors contributed equally to this article.

Page created: May 16, 2016
Page updated: May 16, 2016
Page reviewed: May 16, 2016
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.